Cargill Issued Patent for Glucosamine Production Process

MINNEAPOLISCargill was issued patent #8,034,925, Glucosamine And Method Of Making Glucosamine From Microbial Biomass" for it non-shellfish glucosamine production processes from the United States Patent and Trademark office. 

"Cargill continues to pursue innovations for its glucosamine products and processes," said Mark Christiansen, acidulants product line manager, Cargill Corn Milling North America. "We are committed to producing safe, quality-consistent Regenasure® glucosamine at our state-of-the-art facility in Eddyville, Iowa." 

This patent describes a unique glucosamine composition formed from a vegetarian-based material, as well as a kosher fungal biomass-derived glucosamine suitable for human consumption.

Cargill's Regenasure glucosamine is a U.S.-produced, generally recognized as safe (GRAS) glucosamine that is commercially available, and is also suitable for vegetarians and those with shellfish allergies.

Cargill recognizes and respects the intellectual property of others, and is committed to protecting and enforcing its own intellectual property rights. Cargill has neither licensed nor authorized any other parties to produce glucosamine utilizing the technology covered under patent #8,034,925.

The United States Patent and Trademark office also issued patent #7,816,514 to Cargill on Sept. 2, 2010 for additional features of its glucosamine technology.